Clinical trial for Intractable Epilepsy
Official title Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy
ClinicalTrials.gov ID: NCT07014592
What this study is testing
- What it's testing
- This study is testing whether a new way of recording brain activity can detect how the brain responds to a tiny electrical signal.
- Who it's for
- You may be able to join if you have epilepsy that does not improve with medication.
- What's involved
- You will have special electrodes placed on your scalp to record brain activity while a small electrical signal is applied. The team will measure the brain’s response to this signal.
- Time commitment
- The study lasts a few days, with a single visit for electrode placement and testing. No long‑term follow‑up is required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 75
You may be able to join if
- Patients with medication intractable epilepsy who are recommended to undergo brain surgery to remove a "seizure" focus
- Can provide informed consent for the study and willing to participate
You likely can't join if
- Presence of a permanent electronic implant
- Any chronic medical conditions that prevent safe placement of electrodes
The study team makes the final eligibility decision.
Where it is enrolling
- Ann Arbor, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Ann Arbor, Michigan, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.